Magazine
Email Newsletter
RSS Feed
LinkedIn
Twitter
IN THE NEWS
Chattem Reports Increased Revenues and Earnings
2009-10-06 | 07:47
Personal care brands are strong in recent financial results
The strength of Gold Bond, Act, Icy Hot and Cortizone-10 produced a period of strong earnings and operating results at Chattem, Inc. for the nine months and third quarter ended Aug. 31, 2009, according to the company.
"Our domestic business, representing 95% of our total revenues, achieved growth of 3.9% and 3.5% over the year ago nine and three month periods, respectively, when excluding the discontinued Icy Hot Heat Therapy product from the first quarter of fiscal 2008,” stated Zan Guerry, chairman and chief executive officer of Chattem.
Total revenues for the first nine months of fiscal 2009 rose 1.1% to $353.1 million; while total domestic revenues increased 3.9% to $335.6 million. The increase in domestic revenues was led by sales of Gold Bond, Act, Icy Hot and Cortizone-10. Net income jumped 3.5% to $67.2 million.
Total revenues for the third quarter of fiscal 2009 climbed 2.9% to $115.2 million. Total domestic revenues increased 3.5% to $108.6 million. The increase in domestic revenues was also led by sales of Gold Bond, Act, Icy Hot and Cortizone-10. Net income rose 6.7% to $23.4 million.
"Our domestic business, representing 95% of our total revenues, achieved growth of 3.9% and 3.5% over the year ago nine and three month periods, respectively, when excluding the discontinued Icy Hot Heat Therapy product from the first quarter of fiscal 2008,” stated Zan Guerry, chairman and chief executive officer of Chattem.
Total revenues for the first nine months of fiscal 2009 rose 1.1% to $353.1 million; while total domestic revenues increased 3.9% to $335.6 million. The increase in domestic revenues was led by sales of Gold Bond, Act, Icy Hot and Cortizone-10. Net income jumped 3.5% to $67.2 million.
Total revenues for the third quarter of fiscal 2009 climbed 2.9% to $115.2 million. Total domestic revenues increased 3.5% to $108.6 million. The increase in domestic revenues was also led by sales of Gold Bond, Act, Icy Hot and Cortizone-10. Net income rose 6.7% to $23.4 million.
